Showing 2881-2890 of 5909 results for "".
- Warby Parker is Launching Scout, Its Own Line of Contact Lenseshttps://modernod.com/news/warby-parker-is-launching-scout-its-own-line-of-contact-lenses/2477105/Eyeglasses retailer Warby Parker is launching its own line of contacts, available Tuesday in stores and online. Scout by Warby Parker, a daily lens, is the direct-to-consumer company’s first venture into contact lenses, according to a CNBC
- Tarsius Pharma Announces Granting of Orphan Drug Designation for TRS by the European Medicines Agencyhttps://modernod.com/news/tarsius-pharma-announces-granting-of-orphan-drug-designation-for-trs-by-the-european-medicines-agency/2477104/Tarsius Pharma announced that the European Medicines Agency (EMA) approved the designation of orphan drug for its TRS for treatment of noninfectious uveitis and has acknowledged the clinically relevant advantage for TRS in noninfectious uveitis patients with glaucoma not eligible for corticostero
- FDA Approves First Contact Lens Indicated to Slow Progression of Myopia in Childrenhttps://modernod.com/news/first-contact-lens-for-childhood-myopia-coming-to-the-united-states-in-2020/2477098/The FDA approved the first contact lens indicated to slow the progression of myopia in children between the ages of 8 and 12 years old at the initiation of treatment. The MiSight contact lens made by CooperVision is a single use, disposable, soft contact lens that is discarded at the end of each
- Understanding the Eye’s ‘Plumbing’ Could Lead to Future Treatments for Glaucoma, Other Diseaseshttps://modernod.com/news/understanding-the-eyes-plumbing-could-lead-to-future-treatments-for-glaucoma-other-diseases/2477092/Scientists in the University of Arizona Department of Physiology have identified a potential molecular mechanism that may hold the key to understanding how pressure is regulated in the eye. Funded by a $2.3 million 5-year grant from the National Institutes of Health (NIH) National Eye Inst
- Leica Microsystems and Precision Lens Sign Agreement to Expand Leica Ophthalmic Portfolio in the U.S. Midwesthttps://modernod.com/news/leica-microsystems-and-precision-lens-sign-agreement-to-expand-leica-ophthalmic-portfolio-in-the-u-s-midwest/2477077/Leica Microsystems and Cameron Ehlen Group, d/b/a Precision Lens, have signed an exclusive distribution agreement. Precision Lens will be Leica’s exclusive channel partner for ophthalmic surgical microscopes and digital imaging equipment for the OR in select geographies in the U.S. Midwest.
- Biogen Gains Commercialization Rights to Anti-VEGF Biosimilar Candidates After Deal with Samsung Bioepishttps://modernod.com/news/samsung-bioepis-enters-into-commercialization-agreement-for-next-generation-biosimilar-candidates/2477072/Samsung Bioepis has entered into a new commercialization agreement with Biogen for two biosimilar candidates under development by Samsung Bioepis, SB11 (ranibizumab) and SB15 (aflibercept), in the United States, Canada, Europe, Japan, and Australia. SB11, a biosimilar candidate referencing Lucent
- EyePoint Pharmaceuticals Announces Addition of Dexycu and Yutiq to Department of Veteran Affairs Federal Supply Schedulehttps://modernod.com/news/eyepoint-pharmaceuticals-announces-addition-of-dexycu-and-yutiq-to-department-of-veteran-affairs-federal-supply-schedule/2477065/EyePoint Pharmaceuticals announced that it has signed an interim agreement with the U.S. Department of Veteran Affairs (VA) for Dexycu and Yutiq to be included on the Federal Supply Schedule (FSS), providing U.S. veterans and other federal government agencies with access to both products. The VA
- Regenxbio Exercises Option for Global License for Use of SCS Microinjector in AAV Gene Therapy Deliveryhttps://modernod.com/news/regenxbio-exercises-option-for-global-license-for-use-of-scs-microinjector-in-aav-gene-therapy-delivery/2477053/Clearside Biomedical announced that Regenxbio has exercised its option under the previously announced option and license agreement to license Clearside’s proprietary, in-office SCS Microinjector for the delivery of adeno-associated virus (AAV)-based therapeutics, including but not
- Aerie Pharmaceuticals Announces the Appointment of David A. Hollander, MD, MBA, as Chief Research & Development Officerhttps://modernod.com/news/aerie-pharmaceuticals-announces-the-appointment-of-david-a-hollander-md-mba-as-chief-research-development-officer/2477056/Aerie Pharmaceuticals announced the appointment of David A. Hollander, MD, MBA, as Chief Research & Development Officer, an executive officer position reporting to Vicente Anido, Jr., PhD, Aerie’s Chairman and Chief Executive Officer. Dr. Hollander will commence his employment at Aerie on Nov
- Tangible Hydra-PEG Now Available on More Gas Permeable Contact Lenshttps://modernod.com/news/tangible-hydra-peg-now-available-on-more-gas-permeable-contact-lens/2477047/Tangible Science announced that gas permeable (GP) contact lens materials from Acuity Polymers, Bausch + Lomb, Contamac, Paragon, and SynergEyes are now available for coating with Tangible Hydra-PEG. This expanded list of approved GP lens materials compatible with Tangible Hydra-PEG means that vi